AACR logo

More articles from Immunology

Epstein–Barr Virus–Induced Antitumor Immune Response May Be Harnessable
Cancer Discovery Mar 2021, 11 (3) OF6; DOI: 10.1158/2159-8290.CD-RW2021-005
MEK Inhibition Acts on CD8⁺ T Cells to Enhance Antitumor Immunity
Cancer Discovery Feb 2021, 11 (2) 221; DOI: 10.1158/2159-8290.CD-RW2020-176
HPV Antigen–Specific B Cells in Tumor Microenvironment Characterized
Cancer Discovery Feb 2021, 11 (2) 220; DOI: 10.1158/2159-8290.CD-RW2020-172
Genomic Screens Identify Genes That Regulate MHC-I Expression in DLBCL
Cancer Discovery Feb 2021, 11 (2) OF8; DOI: 10.1158/2159-8290.CD-RW2020-178
Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection
Cancer Discovery Feb 2021, 11 (2) OF7; DOI: 10.1158/2159-8290.CD-RW2020-188
NK Cells Mediate T-cell Inflammation in the Tumor Microenvironment
Cancer Discovery Feb 2021, 11 (2) 223; DOI: 10.1158/2159-8290.CD-RW2020-174
Targetable CD4⁺ T-cell TGFβ Signaling Suppresses Antitumor Immunity
Cancer Discovery Dec 2020, 10 (12) 1785; DOI: 10.1158/2159-8290.CD-RW2020-158
Glucocorticoids Mediate Faulty Tumor-Infiltrating Lymphocyte Function
Cancer Discovery Nov 2020, 10 (11) 1624; DOI: 10.1158/2159-8290.CD-RW2020-140
Tumor Cells Deplete Methionine via SLC43A2, Causing T-cell Dysfunction
Cancer Discovery Nov 2020, 10 (11) 1623; DOI: 10.1158/2159-8290.CD-RW2020-133
Targetable TREM2⁺ Myeloid Cells Mediate Immunsuppression in Tumors
Cancer Discovery Oct 2020, 10 (10) 1439; DOI: 10.1158/2159-8290.CD-RW2020-123

Main menu